South Korea Obesity Treatment Market Size & Outlook

Name: South Korea Obesity Treatment Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The obesity treatment market in South Korea is expected to reach a projected revenue of US$ 357.9 million by 2030. A compound annual growth rate of 17.1% is expected of South Korea obesity treatment market from 2025 to 2030.

South Korea obesity treatment drug class outlook (Revenue, USD million, 2018-2030)
- GLP-1 Receptor Agonists
  - Semaglutide (Wegovy)
  - Liraglutide (Saxenda)
  - Tirzepatide (Zepbound)
- Lipase Inhibitors (Orlistat)
- Appetite Suppressants (Phentermine, Lorcaserin)
- Other Drug Class
South Korea obesity treatment route of administration outlook (Revenue, USD million, 2018-2030)
- Parenteral
- Oral
South Korea obesity treatment distribution channel outlook (Revenue, USD million, 2018-2030)
- Retail Pharmacies
- Hospital Pharmacies
- Other Distribution Channel

South Korea Obesity Treatment Market Size & Outlook

Sign up - it's easy, and free!